Mark W. Elrod
Corporate Officer/Principal bei Kowa Pharmaceuticals America, Inc.
Profil
Mark W.
Elrod is currently the SVP-Medical Education & Sales Training at Kowa Pharmaceuticals America, Inc. He previously worked as the Vice President-Sales at Flamel Technologies SA.
Aktive Positionen von Mark W. Elrod
Unternehmen | Position | Beginn |
---|---|---|
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mark W. Elrod
Unternehmen | Position | Ende |
---|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Vertrieb & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Health Technology |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |